The updated document introduces amendments to paragraph 15, subparagraph 29 of the Procedure for filling out the declaration for goods, approved by the Decision of the Customs Union Commission (CCC) No. 257 dated May 20, 2010. The innovations relate to column 31, where declarants indicate information about cargo items and descriptions of goods.
Now, a more precise and structured description will be required for the raw materials imported for the production of medicines. This will increase the transparency of the import of pharmaceutical raw materials and simplify control over its use in production chains.
Experts note that these changes are aimed at unifying approaches to declaration within the EAEU and are especially important in the context of growing imports of components for pharmaceutical production. It can also reduce the number of errors in paperwork, which will have a positive effect on customs clearance times.
Representatives of logistics and pharmaceutical companies have already begun to prepare for the changes. Many of them are reviewing internal regulations related to paperwork and conducting specialist training.
The transition period until April 2026 will give businesses enough time to adapt. It is important to study the updated requirements in advance in order to avoid problems when importing raw materials and avoid the risks of downtime at customs. It is also recommended to use consultations with customs representatives and automated pre-declaration systems.
The changes in the declaration will not affect the entire flow of goods, but only certain product groups, namely those used in the manufacture of medicines. However, given the growth of the pharmaceutical sector in the EAEU countries, the impact of innovations will be quite wide.
We remind you that the procedure for filling out the DT regulates the registration of basic information about goods when moving across the customs border. Column 31 is one of the key ones, as it contains a description and classification of the product, and any error in it can lead to delays, fines or refusal of registration. Therefore, any changes in this part of the document require close attention from the participants of the foreign economic activity.
